scholarly article | Q13442814 |
P50 | author | Margaret Chung | Q4793511 |
Richard Zimmerman | Q42658961 | ||
Mary Patricia Nowalk | Q63170708 | ||
Min Z Levine | Q92432969 | ||
Brendan Flannery | Q106490202 | ||
Michael Susick | Q114338937 | ||
Kelly Stefano Cole | Q114338952 | ||
P2093 | author name string | Sarah Spencer | |
Judith M Martin | |||
Stacie Jefferson | |||
F Liaini Gross | |||
Krissy Moehling | |||
Crystal Ann Archibald | |||
P2860 | cites work | Immune history shapes specificity of pandemic H1N1 influenza antibody responses. | Q30352126 |
Correlates of protection against influenza infection in humans--on the path to a universal vaccine? | Q30352879 | ||
Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection | Q30366832 | ||
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine. | Q30369136 | ||
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). | Q30382351 | ||
Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. | Q30383312 | ||
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations | Q30401611 | ||
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model | Q33538308 | ||
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? | Q33990541 | ||
Association between antibody titers and protection against influenza virus infection within households | Q34106198 | ||
T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine | Q34338986 | ||
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season | Q34433508 | ||
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season | Q34480810 | ||
Antibody landscapes after influenza virus infection or vaccination. | Q34580640 | ||
Live attenuated and inactivated influenza vaccines in children | Q34974775 | ||
Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. | Q35673054 | ||
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season | Q35805949 | ||
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease | Q35837747 | ||
Global circulation patterns of seasonal influenza viruses vary with antigenic drift | Q35844377 | ||
Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses | Q36051992 | ||
Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine | Q36518793 | ||
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. | Q36977899 | ||
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines | Q37039271 | ||
Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine | Q37091608 | ||
Immunological assessment of influenza vaccines and immune correlates of protection | Q38105339 | ||
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type | Q38410159 | ||
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. | Q40670577 | ||
Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine | Q40870040 | ||
Update: Influenza activity--United States, September 28, 2014-February 21, 2015. | Q41289522 | ||
Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine. | Q41486408 | ||
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season | Q41510283 | ||
Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. | Q41543622 | ||
Update: influenza activity - United States, September 28- December 6, 2014. | Q41672826 | ||
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution | Q42253862 | ||
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses | Q42790878 | ||
Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children | Q43963300 | ||
Comparative efficacy of inactivated and live attenuated influenza vaccines | Q44677378 | ||
Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 | ||
Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season | Q56766119 | ||
Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine | Q79732077 | ||
Weathering the influenza vaccine crisis | Q80879334 | ||
P433 | issue | 10 | |
P921 | main subject | attenuated vaccine | Q1810913 |
P304 | page(s) | 831-839 | |
P577 | publication date | 2016-08-24 | |
P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
P1476 | title | Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination | |
P478 | volume | 23 |
Q49713969 | An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children |
Q40618185 | Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season |
Q47548718 | Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis |
Q50044242 | Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine |
Q52315590 | Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance. |
Q95363302 | Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children |
Q47559760 | Measuring Influenza Neutralizing Antibody Responses to A(H3N2) Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells |
Q90339280 | Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study |
Q59357667 | The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination |
Q64099538 | Unreliable usage of a single influenza virus IgM antibody assay in influenza-like illness: A retrospective study of the 2016-2018 flu epidemic |
Search more.